InMed Pharmaceuticals Inc (INM)

[lesgetrich]

I don't essentially disagree with that point. While bioinformatics, biosynthesis and InMed's drug candidates have huge potential they are currently unproven technologies. InMed doesn't currently have any revenue. It's entire value is in the potential people see in the products it is developing.

That said, however, this is the way pharmaceutical companies have always started and developed. People invest early on in the potential of the company to successfully develop useful drugs and products. Sometimes they're right and the company goes on to make billions in revenue. InMed is a bet, and as such it is just a trade. However, it's a bet I and others are very willing to make.